Terumo (MEX:4543N) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4543N Terumo Corp MEX:4543N
86 GF Score
Price MXN261.28
GF Value MXN349.37
View Full Analysis

What is Terumo Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MEX:4543N
86GF Score
Terumo Corp MEX:4543N
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Terumo (MEX:4543N) Overvalued in 2026?

Based on GuruFocus' analysis, Terumo stock appears to be undervalued. The current stock price of MXN261.28 is trading 25.2% below its estimated GF Value™ of MXN349.37.

Key valuation signals for MEX:4543N:

  • Short Ratio:
  • GF Value™: MXN349.37 vs. price of MXN261.28 (25.2% below fair value)
  • GF Score™: 86/100

No single metric tells the full story. See the MEX:4543N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Terumo Business Description

Address 2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
86GF Score

Get the complete analysis for MEX:4543N

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN261.28
Price
MXN349.37
GF Value